Cambridge Innovation Capital
Paris, France
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. Since our inception in 2013, we have raised £275million to invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.
Founded:2013
Firm Location:Paris, France • London • Cambridge, United Kingdom
Investor Firms That Co-Invest with Cambridge Innovation Capital
Cambridge Innovation Capital Team
Investors in Cambridge (United Kingdom)
Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Investors in Cambridge (United Kingdom)
Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Investors in Cambridge (United Kingdom)
Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in BioTech (Seed), Investors in AI (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Investors in Cambridge (United Kingdom)
Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series A), Investors in FinTech (Series B), Investors in AI (Series A), Investors in FinTech (Series A)
Investors in Cambridge (United Kingdom)
Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in IoT (Series A), Investors in IoT (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Investors in Cambridge (United Kingdom)
Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Christopher Tapper
Sweet spot: $3.3M
Range: $600K - $6.0M
Investors in Cambridge (MA)
Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in FinTech (Series A), Investors in Boston / New England (Other Lists), Investors in London (Other Lists), Investors in FinTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in BioTech (Seed), Investors in AI (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Investors in Cambridge (United Kingdom)
Investors in Material Science (Series A), Investors in Material Science (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)